NanoViricides Seeks Regulatory Approval for Ebola Trial of NV-387 Oral Gummies in DRC

Lantern Pharma Receives EMA Clearance for LP-184 Bladder Cancer Trial in Europe

Nightfood Holdings’ TechForce Robotics Featured in AINewsWire Editorial on Connected Robotics

Earth Science Tech Leverages Vertical Integration to Achieve Dilution-Free Growth and Reduced Liabilities

LataMed AI Partners with Two Caracas Schools to Launch School-Based Telemedicine Services

NeuroOne Reports Real-World Evidence of Seizure Reduction with OneRF Ablation System

From Brooklyn Roots to Retail Giants: Mitch Gould’s Three-Decade Journey in Consumer Products

Medical Device Veteran David Ferrera Urges Focus on Translational Innovation to Bridge Gap Between Ideas and Patient Care

Flow Cytometry Diagnostics Market Projected to Reach $3.5 Billion by 2036, Driven by MRD Testing and Multiparametric Analysis

High-Pressure Glass Autoclaves Market Projected to Reach $355 Million by 2036, Driven by Pharmaceutical R&D and Green Chemistry

Renaissance BioScience Receives Genome BC Funding to Develop RNAi Biopesticide for Soil-Dwelling Pests

GeoVax Advances GEO-MVA Pivotal Study Amid Strategic Reprioritization

VERAXA Biotech Advances Bispecific ADC Program Under OmniAb Collaboration

Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trial, Balances Pipeline with Commercial Product unbuzzd

Onco-Innovations Advances ONC010 Toward Clinical Trials with Manufacturing and Partnership Milestones

Regentis Biomaterials Targets $3B Cartilage Repair Market with GelrinC Regeneration Platform

Earth Science Tech Reports Fiscal 2026 Growth, Advances Integrated Healthcare Platform

Culturally Tailored Navajo Meals Reduce Heart Failure Hospitalizations by More Than Half, Study Finds

Gold Prices Decline as Traders Brace for Fed Meeting Amid Inflation Concerns

Experimental Immunotherapy Shows Promise for Pediatric Brain Cancer

American Fusion Presents Texatron Technology and GEM Unification Theory at APS Particle Physics Conference

VERAXA Biotech Shareholders Overwhelmingly Approve Corporate Governance and Financing Measures

Tonix Pharmaceuticals Schedules Q2 2026 Earnings Call Amid Expansion of CNS and Immunology Pipeline

VERAXA Biotech Advances Bispecific ADC Program VXA-222 Under OmniAb Collaboration

Onco-Innovations Integrates PNKP Inhibitor, Nanoparticle Delivery, and AI to Address Cancer Drug Development Challenges

American Fusion Plans Fusion Testing at Texas Tech, Targets AI Data Centers and Defense

ADAP Advocacy Urges CMS to Take Over Oversight of 340B Drug Pricing Program

Study Reveals Distinct Roles of CHD Proteins in Heart Development, Offering New Insights for Congenital Heart Defects

New Framework for Behçet’s Spectrum Disorders Could Improve Diagnosis and Treatment in Children

SS Innovations to Demonstrate Telesurgery at Robotic Surgery Conference

VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer, Bolstering Solid Tumor Pipeline

Regentis Biomaterials Targets $3 Billion Cartilage Repair Market with GelrinC Platform

Gallup Poll: Nearly 25% of US Employees Stay in Jobs for Health Insurance

OptimumBank Holdings Reports Record Net Income of $6.7 Million in Second Quarter 2026

NanoViricides Raises $3.8 Million in Registered Direct Offering to Fund Antiviral Drug Development

Waterford Lakes Orthodontist Offers Braces and Invisalign With Lifetime Guarantee

Gerresheimer Opens New Plant in China, Doubling Production Capacity for Injectable Pharma Packaging

VERAXA Biotech Receives Regulatory Support from Germany’s Paul-Ehrlich-Institute for BiTAC®-TCE Platform

Onco-Innovations Advances Precision Oncology as Biomarker-Driven Cancer Gains Momentum

American Fusion Expands Texatron Patent Portfolio to 76 U.S. Applications, Prepares for Testing at Texas Tech

Recent Disease Outbreaks Expose Critical Gaps in U.S. Public Health Systems, Expert Says

SS Innovations to Showcase SSi Mantra Robotic System at SRS 2026 with Live Telesurgery Demonstration

Lantern Pharma Receives U.S. Patent Allowance for LP-184 Biomarker-Based Treatment Methods

VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Lead BiTAC Platform Development

Energy Fuels Schedules Q2 2026 Financial Results Conference Call for August 6

BioAdaptives Completes Manufacturing Readiness for Wellness Product Launch

iOrganBio Appoints Harvard Stem Cell Expert Lee L. Rubin to Scientific Advisory Board

Dr. Glen Gillen Emphasizes Human Connection in Healthcare Amid Technological Advances

ERP Software Blog Names Top Microsoft Dynamics BI Tools for 2026

Creative Biolabs Expands Microfluidics Portfolio to Accelerate High-Throughput Antibody Discovery

Neurosurgery and Spine Robot Market to Surge to $4.4 Billion by 2036, Driven by Precision and Minimally Invasive Surgery

Self-powered system recovers water and fertilizer from wastewater

Rubean AG’s SoftPOS App Surpasses 150,000 Active Terminals, Doubling Users Year-Over-Year

Quantum BioPharma Advances Two-Pronged Strategy Against Neurological Disorders

Oncotelic Therapeutics Publishes Preclinical Data Supporting Intravenous Everolimus Formulation for Advanced Solid Tumors

NanoViricides Seeks Approval for Phase II Ebola Trial in DRC Amid Ongoing Outbreak

Study: Balance of Dietary Fats Could Impact Immune System Function

Kairos Pharma Collaborates with Bayer to Test ENV-105 in Combination with Xofigo for Advanced Prostate Cancer

American Fusion Appoints Alec Rossa as Chief Revenue Officer to Drive Commercial Strategy

VERAXA Biotech Receives Positive Regulatory Guidance for BiTAC-TCE Platform from German Authority